Literature DB >> 7406381

Vitamin D metabolite levels in oncogenic osteomalacia.

R A Sweet, J L Males, A J Hamstra, H F DeLuca.   

Abstract

Measurements of 1,25 (OH)2D3 and other metabolites of vitamin D in a patient with oncogenic osteomalacia confirm the selective, reversible deficiency of 1,25 (OH)2D3 in this syndrome, and indicate the rapidity of normalization (within days) of the hormone level and associated hypophosphatemia after resection of the tumor. In this patient, the tumor was an intranasal hemangiopericytoma.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7406381     DOI: 10.7326/0003-4819-93-2-279

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  10 in total

1.  Severe hypophosphataemia in a patient with Paget's disease of bone: paraneoplastic osteomalacia?

Authors:  M D'Amore; F Coluccia; F P Cantatore; M Carrozzo
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.

Authors:  Q L Huang; D S Feig; M E Blackstein
Journal:  J Endocrinol Invest       Date:  2000-04       Impact factor: 4.256

3.  Studies in a patient with tumor-induced hypophosphatemic osteomalacia.

Authors:  W G Ryan; S Gitelis; J R Charters
Journal:  Calcif Tissue Int       Date:  1986-06       Impact factor: 4.333

Review 4.  Phosphaturic mesenchymal tumors: what an endocrinologist should know.

Authors:  J M Boland; P J Tebben; A L Folpe
Journal:  J Endocrinol Invest       Date:  2018-02-14       Impact factor: 4.256

5.  Adult hypophosphatemic osteomalacia: report of two cases.

Authors:  H Rico; F Gomez-Castresana; E R Hernandez; J A Matute; J Torrubiano; M Nunez-Torrón
Journal:  Clin Rheumatol       Date:  1985-09       Impact factor: 2.980

6.  A small cell bronchogenic carcinoma associated with tumoral hypophosphataemia and inappropriate antidiuresis.

Authors:  N Robin; G Gill; C van Heyningen; W Fraser
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

7.  Oncogenic osteomalacia: strange tumours in strange places.

Authors:  D Weiss; R S Bar; N Weidner; M Wener; F Lee
Journal:  Postgrad Med J       Date:  1985-04       Impact factor: 2.401

8.  Alteration in osteoblast activity and nutritional vitamin-D deficiency in non-hypercalcemic malignancy.

Authors:  P S Jowell; S Epstein; F Ismail; B Hollis; I R Schwartz
Journal:  Calcif Tissue Int       Date:  1988-01       Impact factor: 4.333

Review 9.  Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review.

Authors:  Huanwen Wu; Marilyn M Bui; Lian Zhou; Dongmei Li; Hui Zhang; Dingrong Zhong
Journal:  Mod Pathol       Date:  2018-09-11       Impact factor: 7.842

10.  Tumor induced osteomalacia in head and neck region: single center experience and systematic review.

Authors:  Ravikumar Shah; Anurag R Lila; Ramteke-Swati Jadhav; Virendra Patil; Abhishek Mahajan; Sushil Sonawane; Puja Thadani; Anil Dcruz; Prathamesh Pai; Munita Bal; Subhada Kane; Nalini Shah; Tushar Bandgar
Journal:  Endocr Connect       Date:  2019-10       Impact factor: 3.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.